Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satofumi Iida

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Pharmacokinetics|October 1, 2019
Risk of CYP2C9 induction analyzed by a relative factor approach with human hepatocytesChihiro Endo-Tsukude, Motohiro Kato, Akihisa Kaneko, et al.
Drug Research|August 14, 2018
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes MellitusSachiya Ikeda, Yasuki Takano, Dietmar Schwab, et al.
Journal of Clinical Pharmacology|November 19, 2013
A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?Koji Chiba, Hiroyuki Yoshitsugu, Yuto Kyosaka, et al.
Clinical Pharmacokinetics|December 8, 2017
A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia AKoichiro Yoneyama, Christophe Schmitt, Naoki Kotani, et al.
Clinical and Translational Science|December 4, 2024
Population pharmacokinetic analysis identifies an absorption process model for mycophenolic acid in patients with renal transplantYuki Suzuki, Noriko Matsunaga, Takahiko Aoyama, et al.
Drug Research|September 6, 2021
Maxacalcitol Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Secondary Hyperparathyroidism in Patients Receiving Maintenance HemodialysisMizuki Fukazawa-Shinotsuka, Tomohisa Saito, Masaichi Abe, et al.
British Journal of Clinical Pharmacology|January 31, 2018
Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinomaMikiko Nakamura, Chao Xu, Cheikh Diack, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Pharmacokinetics|October 1, 2019
Risk of CYP2C9 induction analyzed by a relative factor approach with human hepatocytesChihiro Endo-Tsukude, Motohiro Kato, Akihisa Kaneko, et al.
Drug Research|August 14, 2018
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes MellitusSachiya Ikeda, Yasuki Takano, Dietmar Schwab, et al.
Journal of Clinical Pharmacology|November 19, 2013
A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?Koji Chiba, Hiroyuki Yoshitsugu, Yuto Kyosaka, et al.
Clinical Pharmacokinetics|December 8, 2017
A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia AKoichiro Yoneyama, Christophe Schmitt, Naoki Kotani, et al.
Clinical and Translational Science|December 4, 2024
Population pharmacokinetic analysis identifies an absorption process model for mycophenolic acid in patients with renal transplantYuki Suzuki, Noriko Matsunaga, Takahiko Aoyama, et al.
Drug Research|September 6, 2021
Maxacalcitol Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Secondary Hyperparathyroidism in Patients Receiving Maintenance HemodialysisMizuki Fukazawa-Shinotsuka, Tomohisa Saito, Masaichi Abe, et al.
British Journal of Clinical Pharmacology|January 31, 2018
Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinomaMikiko Nakamura, Chao Xu, Cheikh Diack, et al.
Pageof 2